Lv1
40 积分 2023-11-15 加入
Landscape of Genomic Mechanisms of Resistance to Selective RET Inhibitors in RET -Altered Solid Tumors: Analysis of the RETgistry Global Consortium
1个月前
已完结
Advances and challenges in targeting FGFR signalling in cancer
1个月前
已完结
Low-grade non-muscle-invasive bladder cancer: molecular landscape, treatment strategies and emerging therapies
1个月前
已完结
The evolving genomic landscape of urothelial carcinoma
1个月前
已完结
Fibroblast growth factor receptors as treatment targets in clinical oncology
1个月前
已完结
FGFR-targeted therapeutics: clinical activity, mechanisms of resistance and new directions
1个月前
已完结
Discovery of TYRA-300: First Oral Selective FGFR3 Inhibitor for the Treatment of Urothelial Cancers and Achondroplasia
2个月前
已完结
Fibroblast growth factor receptor inhibitor erdafitinib promotes Mcl-1 degradation and synergistically induces apoptosis with Bcl-xL/Bcl-2 inhibitor in urothelial cancer cells
3个月前
已完结
Discovery of novel EGFR-PROTACs capable of degradation of multiple EGFR-mutated proteins
5个月前
已完结
Transgenic and knock-out mice for deciphering the roles of EGFR ligands
5个月前
已完结
皖公网安备34019202002308
